Does ALECTINIB Cause Malignant neoplasm progression? 79 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 79 reports of Malignant neoplasm progression have been filed in association with ALECTINIB (ALECENSA). This represents 0.9% of all adverse event reports for ALECTINIB.
79
Reports of Malignant neoplasm progression with ALECTINIB
0.9%
of all ALECTINIB reports
21
Deaths
11
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ALECTINIB?
Of the 79 reports, 21 (26.6%) resulted in death, 11 (13.9%) required hospitalization, and 5 (6.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALECTINIB. However, 79 reports have been filed with the FAERS database.
What Other Side Effects Does ALECTINIB Cause?
Death (702)
Fatigue (618)
Constipation (525)
Off label use (495)
No adverse event (488)
Disease progression (366)
Rash (312)
Dyspnoea (296)
Drug ineffective (269)
Myalgia (268)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ALECTINIB Alternatives Have Lower Malignant neoplasm progression Risk?
ALECTINIB vs ALEMTUZUMAB
ALECTINIB vs ALENDRONATE
ALECTINIB vs ALENDRONATE\CHOLECALCIFEROL
ALECTINIB vs ALENDRONIC ACID
ALECTINIB vs ALEVE